<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01622725</url>
  </required_header>
  <id_info>
    <org_study_id>2012/223</org_study_id>
    <nct_id>NCT01622725</nct_id>
  </id_info>
  <brief_title>Primary and Secondary Ventral Hernia Repair Using Long-term Resorbable Versus Non-resorbable Large Pore Synthetic Mesh.</brief_title>
  <acronym>TIGR</acronym>
  <official_title>Recurrence Rate After Primary and Secondary Ventral Hernia Repair Using Long-term Resorbable Versus Non-resorbable Large Pore Synthetic Mesh.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Ghent</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Novus Scientific</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Ghent</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Since abdominal wall hernia repair is currently performed with the use of a mesh, side
      effects associated with the mesh are frequently reported during long term follow-up. These
      side effects are related to shrinkage of the mesh, adhesions to the bowl, pain, and
      inflammation of the skin and bowl. To reduce or prevent these effects, a fully resorbing mesh
      has been developed, which provides sufficient support and strength to allow efficient
      recovery of the abdominal wall, but also disappear from your body in three years time, so
      that you no longer have any synthetic material in your body. Previous resorbing meshes also
      disappeared but over a much shorter period of time, so that the hernia was insufficiently
      healed, with recurrence as a result.

      The TIGR™ mesh (the resorbable mesh used in the study) is in principle a synthetic mesh, made
      of two commonly used polymers, however it will retain 50% of its initial strength after six
      months. This in theory is enough to provide support of the collagen healing process during
      the initial wound-healing phase, but also to support the transition of initial collagen to
      functional collagen.

      The aim of this study is to compare TIGR™ with large pore mesh used in the repair of the
      anterior abdominal wall repair (incisional hernia, umbilical hernia, etc..Inguinal hernias
      are not part of the study).

      Therefore the patients will be divided into two groups, one group will be treated with a
      resorbing mesh, the other group will be treated with a permanent mesh. Otherwise there will
      be no difference in the medication or the surgical techniques used.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2013</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Recurrence rate at 3 years post-surgery.</measure>
    <time_frame>3 years post-surgery</time_frame>
    <description>Clinical evaluation and ultrasound evaluation after 3 years post-surgery.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Wound Morbidity 4 weeks post-surgery.</measure>
    <time_frame>4 weeks post-surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain and discomfort after 1 year post-surgery.</measure>
    <time_frame>After 1 year post-surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain and discomfort after 3 years post-surgery.</measure>
    <time_frame>After 3 years post-surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recurrence rate by clinical examination 1 year post-surgery.</measure>
    <time_frame>After 1 year post-surgery.</time_frame>
    <description>Clinical Examination to determine the recurrence rate.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">268</enrollment>
  <condition>Primary and Secondary Ventral Hernia</condition>
  <arm_group>
    <arm_group_label>Resorbable mesh</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Long-term resorbable mesh implanted to treat primary and secondary ventral hernia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-resorbable mesh</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Non-resorbable synthetic mesh implanted to treat primary and secondary ventral hernia.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Placing the resorbable mesh</intervention_name>
    <description>Surgery for primary and secondary ventral hernia repair with placing of resorbable mesh.</description>
    <arm_group_label>Resorbable mesh</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Non-resorbable synthetic mesh.</intervention_name>
    <description>Surgery for primary and secondary ventral hernia repair with placing of non-resorbable synthetic mesh.</description>
    <arm_group_label>Non-resorbable mesh</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Primary and secondary ventral hernia

               -  less than 20 cm in length

               -  less than 6 cm in width

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Frederik Berrevoet, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Ghent</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Frederik Berrevoet, MD, PhD</last_name>
    <email>Frederik.Berrevoet@ugent.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ghent University Hospital</name>
      <address>
        <city>Ghent</city>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frederik Berrevoet, MD, PhD</last_name>
      <phone>+32(0)93324892</phone>
      <email>Frederik.Berrevoet@ugent.be</email>
    </contact>
    <investigator>
      <last_name>Frederik Berrevoet, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Leuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc Miserez, MD, PhD</last_name>
      <email>Marc.miserez@uzleuven.be</email>
    </contact>
    <investigator>
      <last_name>Marc Miserez, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Copenhagen</name>
      <address>
        <city>Copenhagen</city>
        <zip>DK-2400</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lars Nannestad Jorgensen, MD, DrMSc</last_name>
      <email>Larsnjorgensen@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Lars Nannestad Jorgensen, MD, DrMSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ul Jagalskiego</name>
      <address>
        <city>Wejherowo</city>
        <zip>84-200</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maciej Smietanski, MD, PhD</last_name>
      <email>smietanski@herniaweb.org</email>
    </contact>
    <investigator>
      <last_name>Maciej Smietanski, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de 12 Octobre</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Teresa Butron Vila, MD</last_name>
    </contact>
    <investigator>
      <last_name>Maria Teresa Butron Vila, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Infirmary of Edinburgh</name>
      <address>
        <city>Edinburgh</city>
        <zip>EH16 4SA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrew de Beaux, MD FRCS MBcChB</last_name>
      <email>Andrew.Debeaux@luht.scot.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Andrew de Beaux, MD FRCS MBChB</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Denmark</country>
    <country>Poland</country>
    <country>Spain</country>
    <country>United Kingdom</country>
  </location_countries>
  <link>
    <url>http://www.uzgent.be</url>
  </link>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 15, 2012</study_first_submitted>
  <study_first_submitted_qc>June 18, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 19, 2012</study_first_posted>
  <last_update_submitted>December 4, 2014</last_update_submitted>
  <last_update_submitted_qc>December 4, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 5, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ventral hernia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasm Metastasis</mesh_term>
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Hernia, Ventral</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

